Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: A nationwide survey of tertiary hospitals in mainland China

J Infect. 2022 Jun;84(6):e108-e110. doi: 10.1016/j.jinf.2022.03.023. Epub 2022 Mar 31.
No abstract available

Keywords: Antimicrobial resistance; Bacterial infections; Carbapenem-resistance; Klebsiella pneumoniae; Survey.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenem-Resistant Enterobacteriaceae*
  • Carbapenems / pharmacology
  • Carbapenems / therapeutic use
  • China / epidemiology
  • Critical Illness
  • Humans
  • Klebsiella Infections* / drug therapy
  • Klebsiella Infections* / epidemiology
  • Klebsiella pneumoniae
  • Microbial Sensitivity Tests
  • Tertiary Care Centers

Substances

  • Anti-Bacterial Agents
  • Carbapenems